Dianthus Therapeutics
DNTH
DNTH
63 hedge funds and large institutions have $406M invested in Dianthus Therapeutics in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
17% more funds holding
Funds holding: 54 → 63 (+9)
0.47% more ownership
Funds ownership: 4.15% → 4.62% (+0.47%)
Holders
63
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$30.1M | |
| 2 | +$9.54M | |
| 3 | +$6.79M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.02M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.52M |
Top Sellers
| 1 | -$3.59M | |
| 2 | -$2.84M | |
| 3 | -$1.67M | |
| 4 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$1.3M |
| 5 |
ACA
Anchor Capital Advisors
Boston,
Massachusetts
|
-$1.03M |